Skip to main content
SpringerLink
Log in

BCR/ABL downregulates DNA-PKCS-dependent and upregulates backup non-homologous end joining in leukemic cells

  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Non-homologous end joining (NHEJ) and homologous recombination repair (HRR) are the main mechanisms involved in the processing of DNA double strand breaks (DSBs) in humans. We showed previously that the oncogenic tyrosine kinase BCR/ABL stimulated DSBs repair by HRR. To evaluate the role of BCR/ABL in DSBs repair by NHEJ we examined the ability of leukemic BCR/ABL-expressing cell line BV173 to repair DNA damage induced by two DNA topoisomerase II inhibitors: etoposide and sobuzoxane. DNA lesions induced by sobuzoxane are repaired by a NHEJ pathway which is dependent on the catalytic subunit of protein kinase dependent on DNA (DNA-PKCS; D-NHEJ), whereas damage evoked by etoposide are repaired by two distinct NHEJ pathways, dependent on or independent of DNA-PKCS (backup NHEJ, B-NHEJ). Cells incubated with STI571, a highly specific inhibitor of BCR/ABL, displayed resistance to these agents associated with an accelerated kinetics of DSBs repair, as measured by the neutral comet assay and pulsed field gel electrophoresis. However, in a functional NHEJ assay, cells preincubated with STI571 repaired DSBs induced by a restriction enzyme with a lower efficacy than without the preincubation and addition of wortmannin, a specific inhibitor of DNA-PKCS, did not change efficacy of the NHEJ reaction. We suggest that BCR/ABL switch on B-NHEJ which is more error-prone then D-NHEJ and in such manner contribute to the increase of the genomic instability of leukemic cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Majsterek I, Blasiak J, Mlynarski W, Hoser G, Skorski T (2002) Does the bcr/abl-mediated increase in the efficacy of DNA repair play a role in the drug resistance of cancer cells? Cell Biol Int 26:363–370

    Article  CAS  PubMed  Google Scholar 

  2. Majsterek I, Slupianek A, Blasiak J (2003) TEL-fusion oncogenic tyrosine kinases determine leukemic cells response to idarubicin. Anticancer Drugs 14:625–631

    Article  CAS  PubMed  Google Scholar 

  3. Majsterek I, Slupianek A, Hoser G, Skorski T, Blasiak J (2004) ABL-fusion oncoproteins activate multi-pathway of DNA repair: role in drug resistance? Biochimie 86:53–65

    Article  CAS  PubMed  Google Scholar 

  4. Slupianek A, Hoser G, Majsterek I, Bronisz A, Malecki M, Blasiak J, Fishel R, Skorski T (2002) Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis. Mol Cell Biol 22:4189–4201

    Article  CAS  PubMed  Google Scholar 

  5. Ahnesorg P, Smith P, Jackson SP (2006) XLF interacts with the XRCC4-DNA ligase IV complex to promote DNA nonhomologous end-joining. Cell 27:301–313

    Article  Google Scholar 

  6. Chen L, Trujillo K, Sung P, Tomkinson AE (2000) Interactions of the DNA ligase IV-XRCC4 complex with DNA ends and the DNA-dependent protein kinase. J Biol Chem 275:26196–26205

    Article  CAS  PubMed  Google Scholar 

  7. Hsu HL, Yannone SM, Chen DJ (2002) Defining interactions between DNA-PK and ligase IV/XRCC4. DNA Repair 1:225–235

    Article  CAS  PubMed  Google Scholar 

  8. Ding Q, Reddy YV, Wang W, Woods T, Douglas P, Ramsden DA, Lees-Miller SP, Meek K (2003) Autophosphorylation of the catalytic subunit of the DNA-dependent protein kinase is required for efficient end processing during DNA double-strand break repair. Mol Cell Biol 23:5836–5848

    Article  CAS  PubMed  Google Scholar 

  9. Adachi N, Iiizumi S, So S, Koyama H (2004) Genetic evidence for involvement of two distinct nonhomologous end-joining pathways in repair of topoisomerase II-mediated DNA damage. Biochem Biophys Res Commun 318:856–861

    Article  CAS  PubMed  Google Scholar 

  10. Wang H, Perrault AR, Takeda Y, Qin W, Wang H, Iliakis G (2003) Biochemical evidence for Ku-independent backup pathways of NHEJ. Nucleic Acids Res 31:5377–5388

    Article  CAS  PubMed  Google Scholar 

  11. Deutsch E, Dugray A, Karim BA, Marangoni E, Maggiorella L, Vaganay S, Kacher R, Rasy SD, Eschwege F, Vainchenker W, Turhan AG, Bourhis J (2001) BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood 97:2084–2090

    Article  CAS  PubMed  Google Scholar 

  12. Gambacorti-Passerini C, Coutre P, Mologni L, Fanelli M, Bertazzoli C, Marchesi E, Di Nicola M, Biondi A, Corneo GM, Belotti D, Pogliani E, Lydon NB (1997) Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cells and induces apoptosis. Blood Cells Mol Dis 23:380–394

    Article  CAS  PubMed  Google Scholar 

  13. Gupta M, Abdel-Megeed M, Hoki Y, Kohlhagen G, Paull K, Pommier Y (1995) Eukaryotic DNA topoisomerases mediated DNA cleavage induced by a new inhibitor: NSC 665517. Mol Pharmacol 48:658–665

    CAS  PubMed  Google Scholar 

  14. Adachi N, Iiizumi S, Koyama H (2005) Evidence for a role of vertebrate Rad52 in the repair of topoisomerase II-mediated DNA damage. DNA Cell Biol 24:388–393

    Article  CAS  PubMed  Google Scholar 

  15. Caldecott K, Banks G, Jeggo P (1990) DNA double-strand break repair pathways and cellular tolerance to inhibitors of topoisomerase II. Cancer Res 50:5778–5783

    CAS  PubMed  Google Scholar 

  16. Czechowska A, Poplawski T, Drzewoski J, Blasiak J (2005) Imatinib (STI571) induces DNA damage in BCR/ABL-expressing leukemic cells but not in normal lymphocytes. Chem Biol Interact 152:139–150

    Article  CAS  PubMed  Google Scholar 

  17. Pastwa E, Poplawski T, Czechowska A, Malinowski M, Blasiak J (2005) Non-homologous DNA end joining repair in normal and leukemic cells depends on the substrate ends. Z Naturforsch 60:493–500

    CAS  Google Scholar 

  18. Wang H, Rosidi B, Perrault R, Wang M, Zhang L, Windhofer F, Iliakis G (2005) DNA ligase III as a candidate component of backup pathways of nonhomologous end joining. Cancer Res 65:4020–4030

    Article  CAS  PubMed  Google Scholar 

  19. Perrault R, Wang H, Wang M, Rosidi B, Iliakis G (2004) Backup pathways of NHEJ are suppressed by DNA-PK. J Cell Biochem 92:781–794

    Article  CAS  PubMed  Google Scholar 

  20. Adachi N, Ishino T, Ishii Y, Takeda S, Koyama H (2001) DNA ligase IV-deficient cells are more resistant to ionizing radiation in the absence of Ku70: implications for DNA double-strand break repair. Proc Natl Acad Sci USA 98:12109–12113

    Article  CAS  PubMed  Google Scholar 

  21. Adachi N, Suzuki H, Iiizumi S, Koyama H (2003) Hypersensitivity of nonhomologous DNA end-joining mutants to VP-16 and ICRF-193: implications for the repair of topoisomerase II-mediated DNA damage. J Biol Chem 278:35897–35902

    Article  CAS  PubMed  Google Scholar 

  22. Nowicki MO, Falinski R, Koptyra M, Slupianek A, Stoklosa T, Gloc E, Nieborowska-Skorska M, Blasiak J, Skorski T (2004) BCR/ABL oncogenic kinase promotes unfaithful repair of the reactive oxygen species-dependent DNA double-strand break. Blood 104:3746–3753

    Article  CAS  PubMed  Google Scholar 

  23. Sallmyr A, Tomkinson AE, Rassool FV (2008) Up-regulation of WRN and DNA ligase IIIalpha in chronic myeloid leukemia: consequences for the repair of DNA double-strand breaks. Blood 112:1413–1423

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was supported by grants 505/363 (JB) and 505/394 (TP) from the University of Lodz.

Author information

Authors and Affiliations

  1. Department of Molecular Genetics, University of Lodz, Banacha 12/16, 90-237, Lodz, Poland

    Tomasz Poplawski & Janusz Blasiak

Authors
  1. Tomasz Poplawski
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Janusz Blasiak
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Janusz Blasiak.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poplawski, T., Blasiak, J. BCR/ABL downregulates DNA-PKCS-dependent and upregulates backup non-homologous end joining in leukemic cells. Mol Biol Rep 37, 2309–2315 (2010). https://doi.org/10.1007/s11033-009-9730-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-009-9730-0

Keywords

Search

Navigation